Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added, replacing the previous v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:23:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Publications section wording was clarified to indicate results of the study, and the revision note updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:38:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Notice about government funding lapse and operating status updates has been removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:47:55.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The updates are minor adjustments that do not modify core study details such as eligibility, endpoints, or enrollment. The study’s primary purpose remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T01:16:14.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:12:57.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Update includes a version upgrade to v3.1.0 and removal of v3.0.2, with several added and removed contact details and identifiers.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:04.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.